Potential concerns over the efficacy of the IL-18BPR variant proteins, as the press release emphasizes the inhibitory challenges previously faced with IL-18 therapies, indicating that overcoming ...

Targeting IL-18BP to Boost Immunity. Graphical Abstract ©ArnaudHUARD/UNIGE. SUMMARY. Interleukin (IL)-18 is an immunoregulatory cytokine that acts as a potent inducer of T helper ...

Sonnet BioTherapeutics (SONN) announced that the United States Patent and Trademark Office has issued a Notice of Allowance to the Company for a second patent in the IL-18 variant protein field ...